Berberine Tannate

鞣酸小檗碱

Report date: 2022/01/14 13:23:58

Base Information

Drug NameBerberine Tannate
Drug Alias Name斯娜格
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsHyperlipidemiasCardiovascular DiseasesBacterial Infections
Global Approved IndicationsBacterial Infections
Approved Indications in ChinaBacterial Infections
Original Approved Country/TerritoryMainland China
Original Approved Date1985/01/01
Country/TerritoryHong KongMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesGansu Longshenrongfa Pharmaceutical Industry Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesThe University Of Hong KongXi'An Disai Biological Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHyperlipidemiasBacterial Infections
Inactive IndicationsCardiovascular Diseases

Other Information

ATC CodeJ01
Related LinksN/A